GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: EBL-3599 is from a series of antibacterial compounds that target UDP-2,3-diacylglucosamine hydrolase (LpxH), an essential enzyme in the lipopolysaccharide synthesis pathway, that is conserved in the majority of Gram-negative bacteria but absent in human [1]. EBL-3599 is a derivative of JEDI-1444 and was identified as part of a programme to develop LpxH inhibitors with activity against efflux-proficient Gram-negative bacteria.
|
|
|||||||||||||||||||||||||||||||||||